全文获取类型
收费全文 | 55428篇 |
免费 | 5143篇 |
国内免费 | 1399篇 |
专业分类
耳鼻咽喉 | 66篇 |
儿科学 | 1959篇 |
妇产科学 | 905篇 |
基础医学 | 3526篇 |
口腔科学 | 836篇 |
临床医学 | 6317篇 |
内科学 | 19727篇 |
皮肤病学 | 194篇 |
神经病学 | 1157篇 |
特种医学 | 579篇 |
外科学 | 2999篇 |
综合类 | 9326篇 |
现状与发展 | 7篇 |
一般理论 | 3篇 |
预防医学 | 4503篇 |
眼科学 | 1025篇 |
药学 | 5728篇 |
40篇 | |
中国医学 | 2704篇 |
肿瘤学 | 369篇 |
出版年
2024年 | 281篇 |
2023年 | 1226篇 |
2022年 | 2032篇 |
2021年 | 2874篇 |
2020年 | 2522篇 |
2019年 | 2268篇 |
2018年 | 2237篇 |
2017年 | 2176篇 |
2016年 | 2373篇 |
2015年 | 2250篇 |
2014年 | 3795篇 |
2013年 | 4366篇 |
2012年 | 3385篇 |
2011年 | 3544篇 |
2010年 | 2844篇 |
2009年 | 2777篇 |
2008年 | 2594篇 |
2007年 | 2484篇 |
2006年 | 2131篇 |
2005年 | 1914篇 |
2004年 | 1586篇 |
2003年 | 1218篇 |
2002年 | 1037篇 |
2001年 | 983篇 |
2000年 | 787篇 |
1999年 | 648篇 |
1998年 | 572篇 |
1997年 | 508篇 |
1996年 | 443篇 |
1995年 | 397篇 |
1994年 | 376篇 |
1993年 | 370篇 |
1992年 | 328篇 |
1991年 | 281篇 |
1990年 | 254篇 |
1989年 | 248篇 |
1988年 | 242篇 |
1987年 | 183篇 |
1986年 | 168篇 |
1985年 | 179篇 |
1984年 | 190篇 |
1983年 | 75篇 |
1982年 | 158篇 |
1981年 | 103篇 |
1980年 | 126篇 |
1979年 | 68篇 |
1978年 | 62篇 |
1977年 | 49篇 |
1976年 | 39篇 |
1970年 | 50篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
61.
目的 观察辛伐他汀(Sim)对白细胞在早期糖尿病大鼠视网膜毛细血管中黏附、堆积的影响,探索他汀类药物可能的非调脂性治疗作用.方法 Wistar大鼠40只,随机分为正常对照组、糖尿病组(DM)、糖尿病Sim组(DMsim)和糖尿病生理盐水组(DM saline).腹腔注射链脲佐菌素(STZ)建立糖尿病模型,成模后Sim组予以Sim15 mg/(kg·d);DMsim组等量灌胃,2周后处死动物,取右眼制备视网膜石蜡切片,行形态学观察及CD45-MAb免疫组织化学研究.结果 CD45在正常大鼠视网膜血管内皮细胞胞膜中有表达,DM组CD45的表达明显增加,与正常对照组、DMsim组比较差异有统计学意义(P<O.05).结论 早期糖尿病大鼠视网膜白细胞黏附性增加,Sim可显著地抑制白细胞在视网膜中的黏附和堆积,改善糖尿病大鼠视网膜微循环. 相似文献
62.
Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy. 总被引:7,自引:0,他引:7
Peter Jacobsen Steen Andersen Kasper Rossing Birgitte V Hansen Hans-Henrik Parving 《Nephrology, dialysis, transplantation》2002,17(6):1019-1024
BACKGROUND: Albuminuria and hypertension are predictors of poor renal and cardiovascular outcome in patients with diabetes. Approximately 30% of type 1 patients with diabetic nephropathy (DN) have albuminuria >1 g/day, and blood pressure >135 and/or >85 mmHg despite antihypertensive therapy with recommended doses of ACE inhibitor (ACEI) and diuretics. We tested the effect of dual blockade of the renin-angiotensin system (RAS) in these patients. METHODS: We performed a randomised double blind crossover trial with 2 months treatment with Irbesartan 300 mg o.d. and placebo added on top of previous antihypertensive treatment. We included 21 type 1 patients with DN responding insufficiently to ACEI and diuretics, as defined above. At the end of each treatment period, albuminuria, 24-h blood pressure and glomerular filtration rate (GFR) were measured. RESULTS: Addition of 300 mg Irbesartan to the patients' usual antihypertensive therapy induced a mean reduction in albuminuria of 37% (95% CI 20-49, P<0.001); from 1574 mg/24 h (95% CI 1162-2132) to 996 mg/24 h (95% CI 699-1419), a reduction in 24-h blood pressure of 8 mmHg systolic (95% CI -2 to 18) and 5 mmHg diastolic (95% CI 1-9) (P=0.11 and 0.01, respectively) (from placebo, mean (SE) 146 (4)/80 (2) mmHg). GFR remained unchanged. Serum potassium increased (mean 4.3 to 4.6 mmol/l, P=0.02). Intervention to reduce serum potassium was needed in two patients with GFR <35 ml/min/1.73 m(2). Otherwise the dual blockade with Irbesartan was safe and well tolerated. CONCLUSIONS: Dual blockade of the RAS may offer additional renal and cardiovascular protection in type 1 patients with DN responding insufficiently to conventional antihypertensive therapy, including recommended doses of ACEI and diuretics. 相似文献
63.
程海东 《复旦学报(医学版)》2002,29(4):294-295,299
目的 研究妊娠期糖尿病与胎儿生长发育中糖代谢特点的关系。方法 选择妊娠期糖尿病25例(GDM组),正常孕妇20例(对照组),分别测孕妇空腹血糖、糖耐量、C肽、IGF-I、新生儿出生2h内空腹血糖,并依据新生儿出生体重分为大于胎龄儿组(LGA组,≥4000g),适于胎龄儿组(AGA组,2500-3999g)。结果 C肽及新生儿出生2h内空腹血糖GDM组与对照组差异有显著性;糖耐量各时点血糖值餐后2h血糖值LGA和AGA组差异有显著性。结论 血糖始终是影响胎儿生长发育的重要因素,孕妇餐后2h血糖水平与巨大儿的发生呈正相关。 相似文献
64.
目的:通过对患者在住院过程中的系统教育,使患者了解自己疾病的知识,提高患者对糖尿病的认知水平和自我管理能力,养成良好的健康行为和生活方式,从而提高生活质量。方法:采用集体、个体、自学等形式进行教育。结果:通过培养,患者掌握了一些基本的操作技能,明显缩短了住院日,同时激发了护士与患者学习专业知识的热情,减少或延缓了并发症的发生。结论:①健康教育是一个护患双边活动过程。②通过教育,可不断提高护士的自身修养和专业知识水平。③健康教育是糖尿病患者学习糖尿病知识,提高自我护理能力的有效途径。 相似文献
65.
Summary To define the glucose to insulin dose-response relationship before the onset of diabetes, we studied 22 nondiabetic co-twins of patients with Type 1 (insulin-dependent) diabetes mellitus and nine control subjects. All had intravenous glucose tests at 0.02, 0.1 and 0.5 g/kg and were followedup prospectively for at least 6 years. Seven twins developed diabetes a mean of 7 months later; the remaining 15 are now unlikely to develop diabetes. The seven pre-diabetic twins had higher fasting insulin levels than control subjects (4.2±2.0 vs 1.8±1.8 nmol/l; p<0.05); but lower glucose clearance (1.0±0.5 vs 1.9±0.7 %/min; p<0.05), first phase insulin response at 0.5 g/kg (21.1±23.2 vs 143±50 nmol/l; p<0.0001), and total insulin responses at 0.1 g/kg (p<0.05) and 0.5 g/kg (p<0.00005). Using a curve-fitting programme, the normal glucose to insulin relationship was lost in prediabetic twins who had lower coefficient of determination (R2) than control subjects (p<0.01). In contrast, 15 low-risk twins and their nine control subjects had similar fasting glucose and insulin levels, glucose clearance, R2 and insulin secretory responses to different glucose loads. The positive predictive values of subnormal R2 and subnormal first phase insulin response were 67 % and 58 % respectively. These observations demonstrate an altered glucose to insulin dose-response relationship and loss of maximum insulin secretory response to glucose before the onset of Type 1 diabetes. 相似文献
66.
应用腹蛇抗栓酶-3治疗94例糖尿病患者并发的脑血栓形成、高脂血症、动脉硬化、神经病变和心绞痛取得较好的疗效。脑血栓形成急性期采用冲击疗法,瘫痪肢体功能恢复迅速、合并神经病变者,治疗后症状消失、神经功能改善。TG、TC、β-脂蛋白水平和TC/HDL比值均降低(P<0.01),HDL水平上升(P<0.01),对比治疗前后血6-Keto-PGF_(1α)、TXB_2和纤维结合素FN的水平改善,具有统计学意义(P<0.01)。 相似文献
67.
Summary Insulin resistance and a defective insulin activation of the enzyme glycogen synthase in skeletal muscle during euglycaemia may have important pathophysiological implications in Type 2 (non-insulin-dependent) diabetes mellitus. Hyperglycaemia may serve to compensate for these defects in Type 2 diabetes by increasing glucose disposal through a mass action effect. In the present study, rates of whole-body glucose oxidation and glucose storage were measured during fasting hyperglycaemia and isoglycaemic insulin infusion (40 mU·m–2min–1, 3 h) in 12 patients with Type 2 diabetes. Eleven control subjects were studied during euglycaemia. Biopsies were taken from the vastus lateralis muscle. Fasting and insulin-stimulated glucose oxidation, glucose storage and muscle glycogen synthase activation were all fully compensated (normalized) during hyperglycaemia in the diabetic patients. The insulin-stimulated increase in muscle glycogen content was the same in the diabetic patients and in the control subjects. Besides hyperglycaemia, the diabetic patients had elevated muscle free glucose and glucose 6-phosphate concentrations. A positive correlation was demonstrated between intracellular free glucose concentration and muscle glycogen synthase fractional velocity insulin activation (0.1 mmol/l glucose 6-phosphate: r=0.65, p<0.02 and 0.0 mmol/l glucose 6-phosphate: r= 0.91, p<0.0001). In conclusion, this study indicates an important role for hyperglycaemia and elevated muscle free glucose and glucose 6-phosphate concentrations in compensating (normalizing) intracellular glucose metabolism and skeletal muscle glycogen synthase activation in Type 2 diabetes. 相似文献
68.
Summary Insulin binding to trophoblast plasma membranes and the placental glycogen content were measured in twelve healthy women, in eleven well-controlled gestational diabetic women who were treated either with diet alone (n=4) or with insulin (n=7) and in 18 women with well-controlled overt diabetes mellitus (six White B; four White C; eight White D). The competitive binding assay was carried out with 22 concentrations of unlabelled insulin. Binding data were analysed by a non-linear direct model fitting procedure assuming one non-cooperative binding site. Maximum specific binding was unchanged in the total collective of gestational diabetic women, but was decreased by 30% in those treated with diet (6.2±2.2%) and increased by 90% in insulin-treated women (16.4±10.2%) as compared to the control subjects (8.7±2.5%). The diet-treated women had only 40% as many and those treated with insulin had more than twice as many receptors compared to control subjects on a per mg protein basis and if expressed per total placenta. In patients with overt diabetes mellitus maximum specific binding (18.5±10.6 %) was higher (p<0.05) due to more receptors compared to control subjects but was similar to the insulin-treated gestational diabetic patients. Maximum specific binding and receptor concentrations did not correlate linearly with maternal plasma insulin levels. Receptor affinities were virtually similar in all groups (1.8·109 l/mol). The placental glycogen content was reduced (p<0.05) to about 80% of that of control subjects in the diet-treated collective, whereas it was unchanged compared to control subjects in the insulin-treated gestational diabetic women despite a 40% increase (p<0.001) of the maternal-to-cord serum glucose ratio. In overt diabetic patients the maternal-to-cord serum glucose ratio and the placental glycogen content were higher (p<0.05) than in the control subjects. We conclude that trophoblast plasma membranes from gestational diabetic women treated with diet alone express less and those from women treated with insulin express more insulin receptors than those from a healthy control group in vitro. These differences could not have been disclosed without consideration of the mode of treatment. Trophoblast plasma membranes from overt diabetic women have more insulin receptors than those from healthy control subjects. 相似文献
69.
We present our experience with twenty children with insulin dependent diabetes mellitus admitted during the past 2 1/2 years.
Sixteen patients were admited with acute onset of ketoacidosis while four were having gradual onset. Active and symptomatic
treatment was started in all diabetic ketoacidotic patients. One patient died during the acute stage. Eleven patients were
followed for 3–6 months or more. Glycosylated hemoglobin was considered as a criteria for control. Three had good control,
two fair and six poor control; six developed diabetic ketoacidosis and three developed hypoglycemia 相似文献
70.